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; lung diseases (Hernandez Rosales, Calunga Fernandez, Turrent Figueras, Menendez Cepero, & Montenegro Perdomo, 2005) ; osteomyelitis (Bilge, Ozturk, Adali, & Ustebay, 2018) . In vitro and animal studies as well as isolated clinical reports suggest the potential role of O2-O3 as an adjuvant therapy for cancer treatment (Clavo et al., 2018) . O2-O3 therapy is accepted by doctors as a non-traditional treatment for its safety, convenience and low cost, since the twentieth century (Hao, Tang, Xie, Li, & He, 2019) .
In this review, we first describe the relevant, well known and documented molecular mechanisms targeted by O3 administration. Secondarily, we highlight how these specific processes could be implicated in cognitive frailty to identify putative therapeutic targets for its treatment and thus to prospectively provide a consistent rationale for applying the O2-O3 therapy in this complex geriatric syndrome.
Oxygen-ozone (O2-O3) therapy
O3 is a triatomic gaseous molecule which has been using as a powerful oxidant in medicine for more than 150 years (Elvis & Ekta, 2011) . In nature, O3 is generated during storms due to the electrical discharges of the rays that react with atmospheric O2 to produce O3. In humans, a revolutionary discovery leaded to ascertain that our body produces oxidants to hurl at invading pathogens, not only as hydrogen peroxide (H2O2), superoxide, hypochlorite and O2 but also O3 as further part of its oxidative armamentarium in fighting infection (Babior, Takeuchi, Ruedi, Gutierrez, & Wentworth, 2003; Lerner & Eschenmoser, 2003; Wentworth et al., 2002) . These studies were performed on neutrophils isolated from human peripheral blood and coated with antibodies and demonstrated that the antibodies can catalyse the generation of O3 by a water oxidation pathway, leading to efficient killing of bacteria.
Van Mauren was the first identifying the distinctive odor of O3 in 1785. The actual gas was later discovered by the German chemist, Christian Friedrich Schonbein at the University of Basel in Switzerland on March 13 th , 1839 when working with a voltaic pile in the presence of O2 (Altman, 2007) . Friederich noticed the emergence of a gas with an electric and pungent smell, and named it J o u r n a l P r e -p r o o f ozone, which is derived from the Greek word for smell . In 1860, Jacques-Louis Soret, a Swiss chemist demonstrated that the O3 was made up of three atoms of oxygen (Altman, 2007) . The first application of O3 as an antiseptic for operating rooms and to disinfect surgical instruments dates to 1856, and in 1860 the first O3 water treatment plant was built in Monaco to disinfect water (Altman, 2007) . The first portable O3 generator was patented by Nikola Tesla in 1896 in the United States.
The use of O3 in the clinical practice was introduced in the past century (Wolff, 1915) .
During the World War I, from 1914 to 1918, doctors used O3 to successfully treat post traumatic gangrene in German soldiers, bone fractures, inflammations and abscesses .
O3 was also used to prevent infections in local medical procedures and to control wound infections because of its prophylactic proprieties (Merin et al., 2007) . The invention of a reliable O3 generator by a physicist, Joachim Hansler, was the major breakthrough in the use of O3 for medical applications. This invention is considered the prelude to the ozonated autohemotherapy procedure and served as the basis for O3 therapy expansion over the last 40 years (Schoop, 1982) .
If the year 2019 brings the signature of the medicine Nobel for "discovery of how cells sense oxygen", O2-O3 therapy acquires to date a further prestigious significance. Indeed, O2 is the most vital element required for human life and it is the key to good health; O3 is O2 with an extra molecule added. The O2 availability affects genes expression of different factors (HIFs, Hypoxia Inducible Factors) leading to the activation of trophic proteins (VEGF, Vascular Endothelial Growth Factor; PDGF, Platelet-derived growth factor) and consequently to specific biological processes including erythropoiesis, angiogenesis and anaerobic glucose metabolism (Zhou et al., 2019 ). If the low availability of O2 leads the cell to rise VEGF, PDGF, HIF genes expression, some studies demonstrated that O3 increases itself the levels of these factors (Curro et al., 2018; Re, Martinez-Sanchez, Perez-Davison, & Sirito, 2010; Zhang et al., 2014) , as if replacing the work of the cell with the role of cellular adapter to hypoxia.
J o u r n a l P r e -p r o o f
O3's action is omni various from immunoregulation and anti-inflammatory properties to antioxidant activity, antimicrobial effect, role in analgesic and vasodilation, blood flow and oxygenation promotion, modulator of regenerative processes and epigenetic modifications (Smith et al., 2017; Travagli et al., 2010; (Figure 1 ).
Immunoregulation and anti-inflammatory and anti-apoptosis properties
Low doses of O3 have been shown to increase secretions of macrophages and leukocytes (Orakdogen et al., 2016) , to enhance the phagocytic capacity of granulocytes and to facilitate the formation of monocytes and activation of T-cells. T-cells defend the body against foreign pathogens: a tyrosine-phosphorylation response takes place immediately in the ZAP-70 molecule when the T-cell antigen receptor (TCR) recognizes any invaders, and then activates phospholipase Cγ1 (PLCγ1) (Smith-Garvin, Koretzky, & Jordan, 2009 ). Membrane lipid phosphatidylinositol-4,5bisphosphate (PIP2) can be hydrolysed by the activation of PLCγ1, therefore, producing two critical second messengers: inositol triphosphate (IP3) and diacylglycerol (DAG). Then, IP3 binds to its receptor (IP3r) located in the endoplasmic reticulum (ER) membrane, leading to calcium (Ca +2 ) from ER into the cytosol. The elevated levels of Ca +2 in cytosol will activate calcineurin, which dephosphorylates nuclear factor activated T-cells (NFAT) and transports it into the nucleus. NFAT then induces the transcription of cytokines, such as Interleukin-(IL)-2, IL-6, IL-8, Tumor Necrosis Factor- (TNFα), and Interferon- (IFNγ), participating in the immune response of the body (Amasaki, 2010) . These cytokines have pro-inflammatory actions that express chemiotactic ability to promote aggregation and infiltrations and enhance the phagocytosis of neutrophils, lymphocytes, macrophages and other inflammatory cells to kill local pathogens (Banerjee, McNish, & Shanmugam, 2017; Wu, R. F. et al., 2017) . IL-6 is the most prominent interleukin, expressed in a variety of tissues and involved in numerous pathophysiological conditions not only immune/inflammation (Sindhu et al., 2015) , but also in mitochondrial myopathy (Rue, Vissing, & Galbo, 2014) , insulin resistance, cell proliferation , apoptosis and cellular senescence (Zhuang et al., 2017) .
J o u r n a l P r e -p r o o f
Through another molecular mechanism, PLCγ1 activates Ras/Mitogen-activated Protein Kinases (MAPK) signalling to promote the translocation of the Activated Protein-1 (AP-1) in the nucleus and activate the immune response (Karin, 1995) . AP-1 is a sequence-specific transcriptional activator composed of members of the Jun and Fos families, whose activity is induced by many stimuli, including not only T-cell activators but also growth factors, cytokines, neurotransmitters.
When O3 is administered intravenously, it dissolves in biological fluids determining a mild oxidative stress (Bocci, V. A., 2006) . Here, O3 reacts with polyunsaturated fatty acids (PUFAs), low-weight molecules such as uric and ascorbic acid and molecules containing thiol groups (cysteine, reduced glutathione or albumin) (Guven et al., 2008) . All these compounds can undergo oxidation by O3, resulting in the formation of H2O2 and Lipid Oxidation Products (Inal, Dokumacioglu, Ozcelik, & Ucar, 2011) . H2O2, a Reactive Oxygen Species (ROS), can act as an O3 messenger for initiating therapeutic and biological effects (Groeger, Quiney, & Cotter, 2009; Guven et al., 2008) . It induces the activation of NFAT or AP-1 and in this way O3 stimulates the innate immune system, helping the cells to survive injury (Reth, 2002) (Figure 1 immunoregulation property via NTAF/AP-1 signalling; Figure 1S for details in molecular pathways).
Members of the nuclear factor-κB (NF-B) and Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) constitute an important network of transcription factors and regulatory proteins that control the expression of a broad array of genes, including those associated with immune and inflammatory responses (Antunes & Han, 2009; Kim, J., Cha, & Surh, 2010) . Pharmacological and genetic studies suggest that there is a functional cross-talk between these two important pathways (Ahmed, Luo, Namani, Wang, & Tang, 2017) .
Cytokines are generated when NF-κB is activated, but at the same time the proinflammatory cytokines TNF-α and IL-1β are activators of NF-κB, giving rise to vicious circle which perpetuate the chronic inflammatory process (Himmelfarb, Stenvinkel, Ikizler, & Hakim, 2002; Kim, J. et al., 2010) . In the absence of stimuli, NF-κB is found in cytoplasm bound to the inhibitory IB proteins. In response to stimuli, IB proteins are rapidly phosphorylated by IB J o u r n a l P r e -p r o o f kinase and ultimately degraded by the 26S proteasome. The resulting release of NF-B and subsequent translocation to the nucleus promote its action on target genes, involved with inflammation, immunity, and apoptosis (Baud & Jacque, 2008; Salminen et al., 2008) . It has been demonstrated that O3 can exert its anti-inflammatory ability, blocking the action of NF-κB, reducing the TNF- concentrations, and causing a reduction of the inflammation and apoptotic cell death (Karouzakis, Neidhart, Gay, & Gay, 2006; Vaillant et al., 2013) . (Figure 1 anti-inflammatory and anti-apoptotic properties via NF-B signalling; Figure 2S for details in molecular pathways).
O3 can perform its anti-inflammatory ability also activating the Nrf2, a member of the CNCbasic leucine zipper (CNC-bZIP) family of transcription factors. Several studies demonstrated that Nrf2 contributes to the inflammatory processes by orchestrating the recruitment of inflammatory cells and regulating gene expression through the antioxidant response element (ARE) (Ahmed et al., 2017) . The kelch-like ECH-associated protein (keap1)/Nrf2 ARE signalling pathway mainly regulates anti-inflammatory gene expression and inhibits the progression of inflammation (Ahmed et al., 2017) . Under basal condition, Nrf2 binds to its repressor Keap1, an adapter between Nrf2 and Cullin 3 protein, which leads to ubiquitination followed by proteasome degradation. Under moderate oxidative stress induced by O3, after heterodimerization with the Muscoloaponeurotic Fibrosarcoma (MAFs), the Nrf2 translocates to the nucleus, where it dimerizes and binds to ARE genes such as heme oxygenase 1 (HO-1), a gene encoding enzyme that catalyses the degradation of heme in carbon monoxide (CO) and free iron, and biliverdin to bilirubin. CO acts as an inhibitor of the NF-B pathway which leads to the decreased expression of pro-inflammatory cytokines, while bilirubin also acts as an important lipophilic antioxidant. Furthermore, HO-1 directly inhibits the pro-inflammatory cytokines and activating the anti-inflammatory cytokines, thus leads to balancing of the inflammatory process (Ahmed et al., 2017) . Keap1 can also prevents NF-B activity via IKK (IκB kinase) inhibition. (Figure 1 anti-inflammatory property via Nfr2 signalling; Figure 2S for details in molecular pathways).
In summary, through its immunoregulation role against injury, different studies reported increased levels of IL-2, TNF, IL-8, IFN-γ and β , IL-1, T-box transcription factor 2, Granulocyte-Monocyte Colony Stimulating Factor (Bocci, V., Luzzi, Corradeschi, & Silvestri, 1994; Bocci, V., Valacchi, Corradeschi, & Fanetti, 1998; Paulesu, Luzzi, & Bocci, 1991; Re et al., 2010; Yong, Lyu, Huang, & Xu, 2017) , but also trophic factors such as transforming grow factor (TGF) β1 (Re et al., 2010; Xiao et al., 2017; Zhang et al., 2014) and  (Feng et al., 2016; Xie, Yan, Lou, & Chen, 2016) after O3 treatment.
Through its anti-inflammatory activity trigged by chronic inflammation, O3 decreases the levels of the pro-inflammatory IL-6, TNF, IL-1and Intercellular Adhesion Molecule 1 (ICAM1) (Chang, Lu, Chang, & Wang, 2005; Xiao et al., 2017; Xie et al., 2016) .
Thanks to its anti-apoptotic role and pro-cell survival and proliferation, O3 administration decreases the expression of caspases 1-3-9, HIF, TNF, Bcl-2-associated X protein (Bax) and p53 genes (Guclu et al., 2016; Yong et al., 2017) . Bax is located in the mitochondrial membranes and exerts pro-apoptosis effect through the mitochondrial pathway, promoting cytochrome C activation (Mac Nair, Schlamp, Montgomery, Shestopalov, & Nickells, 2016); p53 and Caspase-3 are executive molecules of apoptosis by blocking cell cycle . ( Figure 3S Molecular mechanisms for anti-apoptotic property via pro-apoptotic molecules inactivation).
Moreover, O3 stimulates the Kreb's cycle in the mitochondria by enhancing the oxidative carboxylation of pyruvate and stimulating the production of adenosine triphosphate (ATP) (Guven et al., 2008) . It also causes a significant reduction of nicotinamide adenine dinucleotide (NADH), an increase of the coenzyme A levels to fuel the Kreb's cycle and oxidizes cytochrome C (Brigelius-Flohe & Flohe, 2011; Elvis & Ekta, 2011) . The activation of these mechanisms with the blockage of apoptotic mechanisms promotes cell survival and proliferation. In general, as effect on well-being, administrated O3 induces also a release of adrenocorticotropic hormone (ACTH), cortisol and corticotropin-releasing hormone (CRH), dehydroepiandrosterone (DHEA) and endorphins (Dardes, Covi, & Tabaracci, 2017) .
J o u r n a l P r e -p r o o f 2.2 Antioxidant property
The efficacy of O3 therapy is not only through the actions of cytokines but O3 can also reestablish the cellular redox homeostasis (Vaillant et al., 2013) . Oxidative stress, known as the imbalance between production of ROS and their elimination by protective mechanisms such as antioxidants, may be contributing to the neuronal damage and the abnormal neurotransmission. For this, it is implicated in the pathogenesis and progression of various diseases, where brain and mitochondria are the most involved due to their high sensitivity to oxidative damage caused by free radicals.
Nrf2 regulates the constitutive and inducible expression of antioxidant enzymes such as Superoxide dismutases, Glutathione peroxidase, Glutathione-S-Transferase (GST), Catalase, Heme-OH-1, NADPH:quinone oxidoreductase 1 (NQO1), phase II enzymes of drug metabolism and Heat Shock Proteins (HSPs), via cis-acting DNA ARE elements. Many of these enzymes act as free radical scavengers clinically relevant to a wide variety of diseases (Inal et al., 2011) . Under normal conditions, Nrf2 is sequestered in the cytoplasm by its repressor protein, the Keap 1. In response to moderate oxidative stress induced by O3, the Nrf2 is targeted to the nucleus where it binds to the ARE elements of genes encoding the antioxidant and phase II detoxifying enzymes, GST and NQO1 and those that increase glutathione (GSH) biosynthesis (Bocci, V. & Valacchi, 2015; Galie et al., 2018; Pedruzzi, Stockler-Pinto, Leite, & Mafra, 2012) . The presence of Nrf2 can reduce NF-κB activity, via Keap1 protein, leading to increase of HO-1 expression, decrease of proinflammatory cytokines production, and increase of antioxidant defences. To further support this finding, our research group demonstrated that mild ozonisation, tested on in vitro systems, induced modulation of genes including OH-1 (Scassellati et al., 2017) and at mitochondria level, its effect increased the length of the mitochondrial cristae and the content of mitochondrial heat shock protein 70 (HSP 70) . Moreover, O3 treatment was proven to reduce mitochondrial damage in a rat heart following ischemia-reperfusion (Meng et al., 2017) as well as in a rat brain and cochlea following noise-induced hearing loss (Liu et al., 2015) . blocks the activity of NF-B pathway, that in turn cannot stimulate the production of the inducible nitric oxide synthase (iNOS) to synthetize NO (Arias-Salvatierra, Silbergeld, Acosta-Saavedra, & Calderon-Aranda, 2011; Karouzakis et al., 2006; Laskin, Sunil, Guo, Heck, & Laskin, 1998; Manoto, Maepa, & Motaung, 2018) . (Figure 1 antioxidant property via Nfr2 signalling; Figure 2S for details in molecular pathways).
Pathogens inactivation role
Starting from the demonstrated evidence that our immune system produces O3 by antibodies to dispatch their bactericidal activity (Babior et al., 2003; Lerner& Eschenmoser, 2003; Wentworth et al., 2002) , it is clear the importance of its anti-pathogen role against bacteria (both Gram-positive and Gram-negative), fungi, virus, yeast and protozoa. In bacteria, O3 disrupts the integrity of the bacterial cell wall through oxidation of phospholipids and lipoproteins (Polydorou, Halili, Wittmer, 
Role in stimulation of oxygen metabolism and in vascular modulation
It has been demonstrated that O3 increases the red blood cells glycolysis rate (Bocci, V. et al., 2011) . In particular, O3 stimulates 2,3-diphosphoglycerate (DPG) concentration, a direct inhibitor of the affinity of the haemoglobin (Hb) for O2. DPG produces changes in the Hb dissociation curve and displaces the HbO2/Hb equilibrium to the right: HbO2 + 2,3-DPG → Hb -2,3-DPG + O2, so to increase the delivery of O2 to the tissues. Also, in red blood cells O3 stimulates the Kreb's cycle, reduces NADH, oxidizes cytochrome C, with consequent production of ATP and improvement in the blood circulation ( Figure 1 stimulation and modulation property on oxygen metabolism and vasodilation; Figure 4S details for molecular pathways). Multiple studies provide evidence that the activation of antioxidant enzymes after O3 administration can increase erythroblast differentiation. This leads to a progressive increase in erythrocytes and preconditions them to have resilience towards oxidative stress (for review see Elvis & Ekta, 2011) . Additionally, O3 can improve the flexibility of erythrocytes membranes and the rheological proprieties of blood, so to diminish blood viscosity and platelet aggregation (Giunta et al., 2001; Verrazzo et al., 1995) .
O3 induces the production of the vasodilator prostacyclin (Elvis & Ekta, 2011) and stimulates the production of NO by vascular endothelial cells exercising its function of strong endothelium-independent vasodilator (Foresti et al., 2006; Valacchi & Bocci, 2000) . These events favour the vasodilation at the microcirculation level and decreasing of peripheral vascular resistance. More in detail, since HO-1-derived bilirubin has been demonstrated to interact with NO (Barone et al., 2009; Mancuso et al., 2008) , O3-induced HO upregulation could modify NO production and alter vasodilation to maintain normal blood and to attenuate the release of inflammatory cytokines.
As already reported, O3 positive effects have been observed in clinical trials for chronic limb, brain and heart ischemia Dardes et al., 2017; Smith et al., 2017) where reduced red blood cells deformability is a common risk factor. Several studies demonstrated the positive effect of O3 increasing their levels during the injury (Feng et al., 2016; Re et al., 2010; Smith et al., 2017; Ustebay, Ozturk, Bilge, Ustebay, & Tezcan, 2017; Xiao et al., 2017; Xie et al., 2016; Yong et al., 2017; Zhang et al., 2014) . It has been reported that O3 treatment promotes also the fibroblasts migration, increases the levels of collagen, -smooth muscle actinSMA), TGF and inhibits the inflammation in injured fibroblasts (Kim, H. S. et al., 2009; Re et al., 2010; Xiao et al., 2017) .
Role in the regenerative processes
VEGF is a growth factor that promotes new capillary generation, enriches the granulation tissue in the process of wound repair, improves the microcirculation in local wound and provides the nutrients needed for repairing (angiogenesis) (Lord et al., 2017) . EGF is a growth cytokine that can specifically promote epidermal cell proliferation and can accelerate the epithelial process of wound, promote the connective tissue formation and contraction within wound .
FGFs are involved in wound repair, promoting effects on the proliferation of fibroblasts, endothelial cells and keratinocytes and accelerating tissue repair and angiogenesis in local tissues (Cha, Sun, Lee, Choi, & Jung, 2017) . BDNF is expressed in many tissues and it is known to regulate several aspects of neuronal development and function such as survival and differentiation of different neuronal populations, synaptic transmission and plasticity and neuronal repair following injury (Huang & Reichardt, 2001) . It is an important modulator of inflammation (Gezen-Ak et al., 2013; Liang et al., 2015) with crucial antioxidant proprieties , contributing to increase mitochondria performance and to mitigate neuronal metabolic defects following injury (Xu, Lv, Dai, Lu, & Jin, 2018) .
The mammalian or mechanistic target of rapamycin (mTOR) and associated phosphatidylinositiol 3-kinase (PI3K)/protein kinase B (Akt) pathway (PI-3K/AKT/mTOR) regulate cell growth, J o u r n a l P r e -p r o o f differentiation, migration, and survival, as well as angiogenesis and metabolism. This signalling is also a master regulator of protein synthesis and autophagy. For its importance, recent studies support the development of PI3K/Akt/mTOR targeted therapies for groups of severe skin cancers (Chamcheu et al., 2019) . Moreover, EGF and IGF fulfill their functions through the activation of this pathway. Interestingly, the stimulation of PI3K/AKT/mTOR signalling is modulated by O3 treatment to promote wound healing both by increasing the migration of fibroblasts (Xiao et al., 2017) and rising the level of autophagy in a chondrocytes model of osteoarthritis (Zhao et al., 2018) .
The mechanisms underlying the wound healing after O3 treatment consist in two principal pathways (Di Mauro et al., 2019) . O3 can have a topic effect on the skin, producing an antioxidant response, blocking the pro-inflammatory pathway and promoting wound healing processes. On the other hand, O3 can have also systemic effects on platelet activity increasing the production of VEGF, PDGF and TGF, blocking inflammation mechanisms and activating the wound healing. As reported above, its efficacy was observed for different skin diseases/wound healing both in clinical trials and in animal models (Alpan, Toker, & Ozer, 2016; Fitzpatrick et al., 2018; Guclu et al., 2016; Izadi et al., 2019; Kushmakov et al., 2018; Martinez-Sanchez et al., 2005; Ramirez-Acuna et al., 2019; Rosul& Patskan, 2016; Smith et al., 2017; Wang, X., 2018; Xie et al., 2016; Zhang et al., 2014) .
In all these processes, O3 promotes also the release of NO which increases blood circulation for tissue remodelling.
( Figure 1 involvement in the regenerative processes).
Epigenetic modifications
Evidence supported that epigenetic modifications (DNA methylation, noncoding RNAs, histone modifications) play a critical role in the molecular mechanism of oxidative stress. Although it is known that chronic exposure of O3 may be associated with adverse effects (Braidy et al., 2018) , mild oxidative stress caused by therapeutic concentrations of O3 on NF-kB-regulated genes can J o u r n a l P r e -p r o o f influence transcriptional/epigenetic regulators, such as sirtuins, that have been demonstrated to promote lifespan extension (Kawahara et al., 2009; Kawahara et al., 2011) . This corroborates the ontological link between inflammation and aging and allows speculation that O3-induced activation of Nf-KB might be a potential tool to prevent and prolong lifespan trough epigenetic modifications (Figure 1. Epigenetic modulations) .
Rationale of using Oxygen-Ozone therapy in cognitive frailty
Several evidences support the involvement of several systems in the etiopathogenetic mechanisms of cognitive frailty (Abdelhafiz & Sinclair, 2019; Barrera et al., 2018; Panza et al., 2018; Ticinesi et al., 2018) : inflammation, oxidative stress processes, metabolic (diabetes, hypoglycaemia) and endocrine alterations, mitochondrial dysfunctions, stem cells/growth cytokines exhaustion, microbiota modifications are those of major relevance (Figure 2 ). Studies have also found a strong connection with cardiovascular risk factors, cerebrovascular accident, neurodegenerative diseases (Panza et al., 2015) .
Inflammation and oxidative stress systems and endocrine and metabolic dysfunctions
Different evidence supports that inflammaging (chronic low-grade inflammation) is an underlying mechanism of cognitive frailty (Fulop et al., 2010; Li, H., Manwani, & Leng, 2011) .
Alterations in the concentration of immune activation markers, pro-inflammatory molecules and in different lymphocytes subpopulations have been observed in cognitive frail subjects (Baylis et al., 2013; Collerton et al., 2012; Hubbard & Woodhouse, 2010; Marcos-Perez et al., 2017) and chronically high levels of pro-inflammatory biomarkers (i.e TNF-α, IL-6, C-reactive protein, CRP) predict risk of morbidity and mortality in the elderly population (Gonzalez, Woynarowski, & Geffner, 2015) .
As reported in the systematic review of Sargent et al (2018) , some neuroinflammatory markers are associated with cognitive impairment and physical frailty. These included: elevated levels of IL-6, CRP, TNF-, IL-1, IL1-, IL-1 Receptor A (IL-1RA), CD4, CD8, IL-6 Receptor, IL-18, TNF- receptor I, ICAM-1, cortisol/DHEA ratio, uric acid, erythrocyte sedimentation rate, J o u r n a l P r e -p r o o f homocysteine, fibrinogen, circulating osteogenic progenitor cells, and beta 2-microglobulin. ICAM-1 and DHEA are known to affect changes in pro-inflammatory cytokines levels (Corcoran et al., 2010; Hofbauer, Ten, & Khosla, 1999; McCabe et al., 1993; Straub et al., 1998) and play a role in the endocrine system. Interestingly, six genes were found to be associated with cognitive impairment, physical frailty, and sarcopenia in candidate genes association studies: IL-6 with rs1800796, TNF- with rs1800629, IL-18 with rs360722, IL1- with rs16944, and COMT with different SNPs, rs4680 for cognitive decline and rs4646316 for frailty. IL-6, TNF-, IL-18, IL-1 showed corresponding alterations in serum markers associated with cognitive frailty (Panza et al., 2018; Sargent et al., 2018) , suggesting also the well-known functional impact of these cytokines' polymorphisms on the production of circulating proteins. Cardoso et al (2018) On the oxidative stress side, evidence support that increased levels of oxidative stress markers and/or antioxidant deficiencies may pose risk factors for cognitive decline (Berr, Balansard, Arnaud, Roussel, & Alperovitch, 2000) . Two biomarkers were associated to cognitive frailty: malondialdehyde (MDA) and protein carbonyls (Ingles et al., 2014) . In addition, Inglés et al (Ingles et al., 2017) found that plasma BDNF levels decreased significantly in cognitive frail people and a correlation between single nucleotide polymorphism (Met66Val) present in this gene and the decreased plasma BDNF levels in frail people was detected, indicating that the presence of this polymorphism influences its levels. BDNF was also added as high priority marker in the core panel proposed by Cardoso et al (2018) along with IL-6. Starting from the plethora of scientific evidence showing that the differential activation of NFAT, AP-1, NF-kB, Nrf2-ARE and HIF pathways are the main molecular mechanisms J o u r n a l P r e -p r o o f underlying the therapeutic effects of O2-O3 therapy and that their stimulation leads to up-regulation of endogenous antioxidant systems, activation of immune functions as well as suppression of inflammatory processes, we can prospectively assume that O3 administration in frail subjects could protect against the ROS increment, increasing the immune defences against unknown injury and cell survival and proliferation (anti-apoptosis) and at the same time decreasing the inflammaging processes. As the functional impairment in cell-mediated and humoral immunity in frailty (Pinti et al., 2016; Qin et al., 2016) leads to an increased vulnerability to infectious diseases (Mitnitski, A. et al., 2015) , O3 administration could contribute also through its anti-microbial functions. (Figure 3) .
Oxidative stress is one of the major drivers of protein misfolding that, when they accumulate and aggregate as insoluble inclusions can determine multiple aging-related neurodegenerative and metabolic disorders (Knowles, Vendruscolo, & Dobson, 2014) . If Nfr2 promotes the clearance of oxidized or otherwise damaged proteins through the autophagy mechanism , it is conceivable that O3 by Nfr2 can modulate the degradation protein systems, also through the activation of PI-3K/Akt/mTOR signalling (pro-autophagy role) (Zhao et al., 2018) . This rationale is strengthened by the consolidate evidence that O3 administration, thought its functions of antioxidant and anti-inflammation, has positive effects on different chronic diseases where it is important to correct inflammation and stress oxidative. Coppola et al (Coppola et al., 2010) found that geriatric patients after O3 treatment exhibited significant improvements in mood tones according to Montgomery-Asberg Depression Rating and Hamilton Depression Rating scales and this was also accompanied by an increase of BDNF levels, as if O3 and BDNF acted as antidepressant medications. Moreover, it has been observed that a significant decline in sirtuin 1 levels was observed in individuals with cognitive frailty compared to age matched healthy individuals Kumar, S., Vikram, Kim, S Jacobs, & Irani, 2014) , suggesting that O3 could be involved in preventing aging and prolonging lifespan.
Taking in consideration other properties of O3 such as the improvement of blood circulation and oxygen delivery to ischemic tissue, an increase in 2,3-DPG level, an increase in reduced J o u r n a l P r e -p r o o f glutathione, an enhancement in basal metabolism through improved oxygen delivery, the induction of HSP-70 and the increased release of growth factors (VEGF, PDGF, EGF, FGF, IGF, BDNF), CRH, ACTH, DHEA, cortisol, we prospectively can hypothesize that O3 treatment could correct the metabolic and endocrine functions impaired in cognitive frailty and in the same way also those linked to the cardiovascular diseases, risk factors for frailty. It is well known the positive effect of O3 on diabetes in clinical and animal models studies (Alpan et al., 2016; Guclu et al., 2016; Martinez-Sanchez et al., 2005; Ramirez-Acuna et al., 2019; Rosul& Patskan, 2016; Xie et al., 2016) , cardiovascular and peripheral vascular diseases (Dardes et al., 2017; Smith et al., 2017) . (Figure 3) .
Mitochondrial dysfunctions
With aging and in cognitive frailty there is an increase in mitochondrial disfunctions with consequent increased in ROS for lowered oxidative capacity and antioxidant defence, and thus increased oxidative damage to protein and lipids, decreased ATP production and accumulation of DNA damage (Barrera et al., 2018; Boccardi, Comanducci, Baroni, & Mecocci, 2017) .
Interestingly, multiple lines of evidence have shown that Nfr2 activation is part of the retrograde response aimed at restoring mitochondrial functions after stress insults, and that the impairment of Nrf2 functions is a hallmark of many mitochondrial-related disorders (Shan et al., 2013) . (Figure 2 Mitochondria dysfunctions). Thus, it is conceivable the role of O3 on mitochondrial disfunctions in cognitive frailty, through the up-regulation of endogenous antioxidant systems via Nrf2 signaling.
Also, its property to activate the Kreb's cycle and reduce the NADH promotes the production of ATP. The induction of anti-apoptotic mechanisms where O3 treatment decreases the Bax gene expression level in mitochondria (Mac Nair et al., 2016) as well as restores mitochondrial damaging in animal models (Liu et al., 2015; Meng et al., 2017) , permits to suggest its further potential role in the renewing mitochondria functions in cognitive frailty. (Figure 3 ).
Stem cell/growth cytokines exhaustion
J o u r n a l P r e -p r o o f An endogenous stem cell production and function decreases with age and this decline likely contributes to reduced ability to regenerate and repair organs and tissues (Jones & Rando, 2011; Yu& Kang, 2013; Zhuo et al., 2010) . There is evidence that as mesenchymal stem cells (MSCs) undergo senescence, their properties of multilineage differentiation, immunomodulation and wound healing gradually disappear (Raggi & Berardi, 2012) . Altered and dysfunctional stem cell niches have been implicated in frailty syndrome (Golpanian et al., 2016; Lopez-Otin, Blasco, Partridge, Serrano, & Kroemer, 2013) . As such, it has been proposed that a regenerative medicine therapeutic approach has the potential to improve or reverse the signs and symptoms of frailty (Kanapuru & Ershler, 2009; Raggi & Berardi, 2012) (Figure 2 . Alterations in regenerative system). Through the O3's action on growth cytokines (VEGF, PDGF, EGF, FGF, IGF, TGF, BDNF, PI-3K/AKT/mTOR signalling), we hypothesised that prospectively O2-O3 could be considered as a regenerative medicine approach for cognitive frailty, improving the regeneration systems, angiogenesis, cellular proliferation, differentiation, tissue regeneration (Figure 3 ).
It is widely known the O3 involvement and positive effects on skin disorders, wound healing (Di Mauro et al., 2019) characterized by three overlapping but distinct stages: inflammation (O3 kills microorganism and activates immune system), tissue proliferation (O3 increases the expression of TGF- and VEGF) and remodelling (O3 promotes the release of NO to increase blood circulation). Moreover, the evidence that Nfr2 is involved in the adipogenic differentiation of MSCs along with HO-1 (Vanella, Sanford, Kim, Abraham, & Ebraheim, 2012) and that low O3 concentrations exerted an adipogenic effect on human adipose-derived adult stem cells in the absence of damage in differentiated adipocytes (Cisterna et al., 2019) suggests the role of the mild ozonisation as an adjuvant tool for tissue regeneration and engineering.
Microbiota-gut-brain axis and microbiota alterations
Several lines of evidence suggest that the gut microbiota (ensemble of bacteria, fungi, viruses, protozoa and archaea symbiotically living in the distal human gastrointestinal tract) is an important part of the microbiota-gut-brain axis. This includes multiple bidirectional systems J o u r n a l P r e -p r o o f through which the gut microbiota and the brain communicate, encompassing hormonal Hypothalamic Pituitary Axis, (HPA), neuronal (vagus nerve), and immune systems. In a homeostatic state, a healthy gastro-intestinal tract has a normal and stable commensal intestinal microbiota and provides the host with nutrition and energy by producing vitamins. Aging associated alterations lead to variations in the composition of the intestinal microbiota probably contribute to immunosenescence and the development of a proinflammatory phenotype (Gomez-Gomez & Zapico, 2019) . Inflammatory aging, in turn, can significantly alter brain function due to an increase in the expression of inflammatory cytokines and increase oxidative stress, the breakdown of the blood-brain barrier, the infiltration of peripheral immune cells, and glial cell activation. It is likely that these processes contribute to the cognitive frailty (Gomez-Gomez & Zapico, 2019) . Some studies reviewed in Ticinesi et al., 2018) found overrepresentation of Enterobacteriaceae and Fusobacteriaceae, and identified some taxa, namely Alcaligenaceae, Porphyromonadaceae, Lactobacillales positively correlated with cognitive impairment. Lactobacillus, Lactococcus, Streptococcus and Enterococcus may produce histamine, which acts as a neurotransmitter and an important modulator of neuroinflammation, through reduction of TNF expression in the brain.
Bacillus, Lactobacillus and Bifidobacterium, can synthesize neurotransmitters involved in memory and learning function regulation, such as gamma-aminobutyric acid, serotonin, norepinephrine and acetylcholine. Clostridium may also produce indole-3-propionic acid, a relevant antioxidant for neurons. (Figure 2 Gut microbiota alterations).
Thus, if the manipulation of gut microbiota can improve cognitive functions, thanks to its anti-inflammation, anti-oxidant, strong bactericidal, fungicidal, antiviral, and anti-protozoal activities (Duricic, Valpotic, & Samardzija, 2015; Sato, Wananabe, & Miyata, 1990; Sugita et al., 1992) , along with its positive effects on gastrointestinal (hepatitis, cirrhosis, ulcerative colitis) diseases (Elvis & Ekta, 2011; Smith et al., 2017; Sukhotnik et al., 2015) O3 intervention could represent a potential preventive and therapeutic intervention for cognitive frailty (Figure 3 ). Of J o u r n a l P r e -p r o o f note, it has been demonstrated a significant positive effect of O3 in patients with intestinal dysbiosis (Loprete & Vaiano, 2017) .
Concluding remarks.
Looking for alternative and new interventions for cognitive frailty, we suggest that O2-O3 therapy could be a useful, safe, no-invasive, no-pharmacological, economical, effective treatment for this condition. The mechanisms of the positive effects of O3 are mainly attributed to activation of the immune and anti-inflammatory systems, up-regulation of cellular antioxidant enzyme activity, enhancement in the release of growth factors from platelets, improvement in blood circulation and O2 delivery to damaged tissues, and enhanced general metabolism (Bocci, V., 2004; Bocci, V., 2011; Bocci, V. A., 2006) , along with being a potent bactericide, fungicide and virucidal with potential effect on gut microbiota. Consequently, these combinatorial effects could impact on cognitive domains directly or indirectly through the mediation of gut microbiota. Nrf2-ARE, NF-κB, NFAT, AP-1, HIF are principal signalling pathways on which O3 exercises its effects, that could be sharable with those involved in cognitive frailty, where high inflammation and oxidant state, endocrine and metabolic alterations, mitochondria dysfunctions and slowdown in regenerative processes and immune system characterize this geriatric condition.
Recently, Cuadrado et al. (2019 Cuadrado et al. ( , 2018 reported extensive evidence about the central role playing by Nrf2 as master regulator of multiple cytoprotective responses and the key molecular node within a particular cluster of a wide spectrum of diseases: from cardiovascular (atheroscelorosis coronary artery disease) to metabolic (diabetes, hyperglycemia), respiratory (emphysema, chronic obstructive pulmonary disease), neurodegenerative (Alzheimer's and Parkinson's Diseases) and digestive (steatosis, non-alcoholic steatohepatitis, cirrhosis) diseases. All these pathologies show sharable common mechanisms, including oxidative, inflammatory, and metabolic alterations, molecular systems implicated also in cognitive frailty. As it has been suggested, keeping in mind that Nrf2 could represent a new strategy for therapeutic approaches J o u r n a l P r e -p r o o f (Cuadrado et al., 2018; Cuadrado et al., 2019) , O2-O3 therapy acquires a significant value for its known and widely demonstrated interaction with Nfr2.
Medical O3 is a mixture of O3 in O2 under therapeutic (10-40 gO3/ml of O2) or antibiotic (60-100 g/ml) concentrations, generated by certificated apparatus and applied according to local or systemic routes of administration (Dardes et al., 2017) . O3 medical preparations are classified into three types: ozonized water, ozonized oil and ozonized gas. At present, a randomized double-blind clinical trial has commenced with the aim to test the efficacy of this therapy in a cognitive frailty cohort, a project approved by the Italian Minister of Health (RF-2016-02363298). This pilot study will permit to validate the O2-O3 therapy in an early phase of cognitive decline when it is still possible to intervene before to develop a potential neurodegenerative pathology. We believe that this therapy could replace the multidomain approach currently available for cognitive frailty due to the omni various functions of the O3: a monodomain intervention with O2-O3 therapy could be faster, easier, inexpensive, predictable and conservative with much more efficacy results.
Importantly, several studies reported that this therapy works in absence of side effects (Delgado-Roche et al., 2017; Hao, Tang, Xie, Li, & He, 2019; Martinez-Sanchez & Re, 2012; Re et al., 2008; Re et al., 2014) , and this could overcome those linked to the use of anti-inflammatory and antioxidant medications for which high doses could cause toxicity (Gomez-Gomez & Zapico, 2019), whereas the efficacy of antioxidants in reducing the concentrations of aldehydes and/or proteinaldehyde adducts in blood or in tissues has not been evaluated yet (Gomez-Gomez & Zapico, 2019) .
With the awareness that further studies are needed, this review reports substantial scientific evidence for building a rationale of using the O2-O3 therapy for the early stage of cognitive decline, exploiting well documented omni various functions of O3. This therapy could represent a convenient, inexpensive monodomain intervention, working in absence of side effects that will permit to modulate the immune, inflammatory, oxidant, metabolic, endocrine, microbiota and regenerative processes impaired in cognitive frailty. 
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